
Reset all filters
01 1Eli Lilly And Company Indianapolis US
Reset all filters
01 1Zinc insulin crystals, Product numbers QA241B, ID4028
Reset all filters
01 1U.S.A
Reset all filters
01 1Withdrawn by Holder
Zinc Insulin Crystals, Product Numbers QA241B, I...
Certificate Number : R0-CEP 2000-313 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2005-02-28
Type : TSE
Substance Number :
79
PharmaCompass offers a list of Caninsulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Caninsulin manufacturer or Caninsulin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Caninsulin manufacturer or Caninsulin supplier.
PharmaCompass also assists you with knowing the Caninsulin API Price utilized in the formulation of products. Caninsulin API Price is not always fixed or binding as the Caninsulin Price is obtained through a variety of data sources. The Caninsulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Insulin novo lente manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Insulin novo lente, including repackagers and relabelers. The FDA regulates Insulin novo lente manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Insulin novo lente API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Insulin novo lente supplier is an individual or a company that provides Insulin novo lente active pharmaceutical ingredient (API) or Insulin novo lente finished formulations upon request. The Insulin novo lente suppliers may include Insulin novo lente API manufacturers, exporters, distributors and traders.
click here to find a list of Insulin novo lente suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Insulin novo lente CEP of the European Pharmacopoeia monograph is often referred to as a Insulin novo lente Certificate of Suitability (COS). The purpose of a Insulin novo lente CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Insulin novo lente EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Insulin novo lente to their clients by showing that a Insulin novo lente CEP has been issued for it. The manufacturer submits a Insulin novo lente CEP (COS) as part of the market authorization procedure, and it takes on the role of a Insulin novo lente CEP holder for the record. Additionally, the data presented in the Insulin novo lente CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Insulin novo lente DMF.
A Insulin novo lente CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Insulin novo lente CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Insulin novo lente suppliers with CEP (COS) on PharmaCompass.
We have 1 companies offering Insulin novo lente
Get in contact with the supplier of your choice: